identified three distinct stroma types (FAP/ACTA2-dominant fibroblast-rich stroma and collagen-rich stroma) in human pancreatic cancer (44), which were differentially associated with the immunosuppressive TME and patient outcomes. This evidence concerns the gene ACTA2 and pancreatic neoplasm.